Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin

Abstract

Cytomegalovirus (CMV) antigenemia assay enables a rapid, quantitative, and noninvasive monitoring of CMV infection, which is widely used as a sign for starting preemptive therapy with ganciclovir after allogeneic hematopoietic stem cell transplantation. Nichols et al[1][1] recently reported that